Adelaide Research & Scholarship: Search

Search

Results 1-10 of 12 (Search time: 0.003 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2020	Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration	Po uha, S.T.; Le Grand, M.; Brandl, M.B.; Gifford, A.J.; Goodall, G.J.; Khew-Goodall, Y.; Kavallaris, M.
	2021	Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: guidance using optical window intravital FRET imaging	Floerchinger, A.; Murphy, K.J.; Latham, S.L.; Warren, S.C.; McCulloch, A.T.; Lee, Y.-K.; Stoehr, J.; Mélénec, P.; Guaman, C.S.; Metcalf, X.L.; Lee, V.; Zaratzian, A.; Da Silva, A.; Tayao, M.; Rolo, S.; Phimmachanh, M.; Sultani, G.; McDonald, L.; Mason, S.M.; Ferrari, N.; et al.
	2023	Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts	Wu, Y.; Clark, K.C.; Niranjan, B.; Chüeh, A.C.; Horvath, L.G.; Taylor, R.A.; Daly, R.J.
	2013	The genomic landscape of hypodiploid acute lymphoblastic leukemia	To, L.
	2018	Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cells	Paquet-Fifield, S.; Koh, S.L.; Cheng, L.; Beyit, L.M.; Shembrey, C.; Mølck, C.; Behrenbruch, C.; Papin, M.; Gironella, M.; Guelfi, S.; Nasr, R.; Grillet, F.; Prudhomme, M.; Bourgaux, J.F.; Castells, A.; Pascussi, J.M.; Heriot, A.G.; Puisieux, A.; Davis, M.J.; Pannequin, J.; et al.
	2018	Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy	Marini, K.D.; Croucher, D.R.; McCloy, R.A.; Vaghjiani, V.; Gonzalez-Rajal, A.; Hastings, J.F.; Chin, V.; Szczepny, A.; Kostyrko, K.; Marquez, C.; Samantha, W.; Jayasekara, N.; Alamgeer, M.; Boolell, V.; Han, J.Z.R.; Waugh, T.; Lee, H.C.; Oakes, S.R.; Kumar, B.; Harrison, C.A.; et al.
	2012	ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression	Ahn, Y.; Gibbons, D.; Chakravarti, D.; Creighton, C.; Rizvi, Z.; Adams, H.; Pertsemlidis, A.; Gregory, P.; Wright, J.; Goodall, G.; Flores, E.; Kurie, J.
	2011	Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression	Wang, Q.; Bailey, C.; Ng, C.; Tiffen, J.; Thoeng, A.; Minhas, V.; Lehman, M.; Hendy, S.; Buchanan, G.; Nelson, C.; Rasko, J.
	2013	Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors	Waibel, M.; Solomon, V.; Knight, D.; Ralli, R.; Kim, S.; Banks, K.; Vidacs, E.; Virely, C.; Sia, K.; Bracken, L.; Collins-Underwood, R.; Drenberg, C.; Ramsey, L.; Meyer, S.; Takiguchi, M.; Dickins, R.; Levine, R.; Ghysdael, J.; Dawson, M.; Lock, R.; et al.
	2015	Cabozantinib inhibits abiraterone's upregulation of IGFIR phosphorylation and enhances its anti-prostate cancer activity	Wang, X.; Huang, Y.; Christie, A.; Bowden, M.; Lee, G.; Kantoff, P.; Sweeney, C.